Evidence map›Paper›PMID 36696034›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2023

Cerebellar α6GABA

Ya-Hsien Huang, Ming Tatt Lee, Han-Yun Hsueh, Daniel E Knutson, James Cook, Marko D Mihovilovic, Werner Sieghart, Lih-Chu Chiou

Open access · bronzeAbstract read
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Why Can Modulation of α6-Containing GABAArchives of pharmacology and therapeutics · 2024
    Article
  7. Article
  8. A Role for GABATremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Article
  9. Review
  10. GABANeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Ya-Hsien HuangDepartment and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Section 1, Taipei, 10051, Taiwan.
Ming Tatt LeeDepartment and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Section 1, Taipei, 10051, Taiwan.
Han-Yun HsuehDepartment and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Section 1, Taipei, 10051, Taiwan.
Daniel E KnutsonDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, 53211, USA.
James CookDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, 53211, USA.
Marko D MihovilovicInstitute of Applied Synthetic Chemistry, TU Wien, Vienna, 1060, Austria.
Werner SieghartCenter for Brain Research, Department of Molecular Neurosciences, Medical University Vienna, Vienna, 1090, Austria.
Lih-Chu ChiouDepartment and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Section 1, Taipei, 10051, Taiwan. lcchiou@ntu.edu.tw.ORCID 0000-0001-5356-940X
National Taiwan University · TWUniversity of Wisconsin–Milwaukee · USMedical University of Vienna · ATTU Wien · AT

Funding

GABA-A receptor subtype mechanisms and the abuse-related effects of alcoholR01AA029023 · NIAAA · UNIVERSITY OF MISSISSIPPI MED CTR · PI PLATT, DONNA M · 2020 to 2024
$2.4M
Design of New Therapeutic Agents to Treat SchizophreniaR01MH096463 · NIMH · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COOK, JAMES M · 2013 to 2017
$1.9M
NIAAA NIH HHS R01 AA029023NIMH NIH HHS R01 MH096463
6 · The paper itself

Abstract

Ethanol has been shown to suppress essential tremor (ET) in patients at low-to-moderate doses, but its mechanism(s) of action remain unknown. One of the ET hypotheses attributes the ET tremorgenesis to the over-activated firing of inferior olivary neurons, causing synchronic rhythmic firings of cerebellar Purkinje cells. Purkinje cells, however, also receive excitatory inputs from granule cells where the α6 subunit-containing GABA

Indexed as

Essential TremorAnimalsEthanolHarmalineMaleMiceMice, Inbred ICRPropranololReceptors, GABA-ATremorEthanolHarmalinePropranololReceptors, GABA-ACerebellumEssential tremorEthanolGABAA receptor α6 subunitGABRA6Harmaline

Identifiers

PMID36696034
PMCPMC10121996
OpenAlexW4317952774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.